Articles related to COMMUNITY-ACQUIRED PNEUMONIA (CAP)

ICU mortality rates for Legionella pneumonia can reach up to 41.7%, with immunocompromised patients facing particularly high risk – making proper diagnosis and treatment crucial in severe cases.

A comprehensive analysis of more than 2 million hospitalizations across 115+ US VA medical centers has revealed that 57% of patients treated for pneumonia experienced discordances between their initial and discharge diagnoses.

This case study reveals how acute pneumonic toxoplasmosis can manifest as severe pneumonia in immunocompetent adults, challenging standard diagnostic protocols and emphasizing the importance of considering zoonotic sources in atypical presentations.

Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.

In this study, 800 patients admitted to ICU for severe CAP were andomized to 200mg IV hydrocortisone daily for 4 to 8 days or to placebo. By day 28, mortality rate was 6.2% versus 11.9% for the steroid and placebo groups, respectively. Rates for intubation and vasopressors were both approximately 40% lower in the test group as well.

A 59-year-old man is hospitalized with a five-day history of nonproductive cough and fever. The patient reports that he recreationally breeds carrier pigeons and reports no travel outside of the United States. After a physical exam and chest radiograph, what is the most likely cause of this patient’s symptoms?